Formulations:
- Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial
Indications:
- Malignant neoplasm metastasis in large intestine
- Malignant neoplasms of kidney, except renal pelvis
- Rhabdomyosarcoma primary site
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 40 mg per 2 mL in 2 mL vial; 100 mg per 5 mL in 5 mL vial; 500 mg per 25 mL in 25 mL vial
Indications:
- Malignant neoplasm metastasis in large intestine
- Malignant neoplasms of kidney, except renal pelvis
- Rhabdomyosarcoma primary site
Source: EML workbook import